logo

David Kelley, MD

David Kelley, MD

Endocrinology Pittsburgh, PA

Physician

Office Address

Office Map
  • 3601 5th Ave
    Falk Clinic, Suite 2b
    Pittsburgh, PA 15213
    Phone: (412) 383-8700

Dr. Kelley's Clinical Specialties & Interests

  • Endocrinology: Diabetes

Dr. Kelley's Education & Medical Training

  • Mayo School of Graduate Medical EducationMayo School of Graduate Medical EducationFellowship, Endocrinology, Diabetes and Metabolism
  • University of MarylandUniversity of MarylandResidency, Internal Medicine
  • Oregon Health & Science UniversityOregon Health & Science UniversityResidency, General Surgery
  • U of MD Sch of MedUniversity of Maryland School of MedicineMedical School

Dr. Kelley's Certifications & Licensure

  • NJ State Medical LicenseNJ State Medical License2008 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineEndocrinology & Metabolism

Dr. Kelley's Clinical Trials

Dr. Kelley's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Look Ahead Ancillary Study: Fat Cell Size, Muscle Lipid Infiltration
    Look Ahead Ancillary Study: Fat Cell Size, Muscle Lipid InfiltrationNational Center For Research Resources
    2005 - 2005
  • Look Ahead: Ancillary Study: MRI Derived Organ Tissue Mass Weight Loss
    Look Ahead: Ancillary Study: MRI Derived Organ Tissue Mass Weight LossNational Center For Research Resources
    2005 - 2005
  • Mitochondrial Impairment In Muscle Insulin Resistance
    Mitochondrial Impairment In Muscle Insulin ResistanceNational Center For Research Resources
    2005 - 2005
  • PET Imaging Of Regional Variation In Insulin Sensitivity Of Fatty Tissues Humans
    PET Imaging Of Regional Variation In Insulin Sensitivity Of Fatty Tissues HumansNational Center For Research Resources
    2005 - 2005
  • Multi-Tracer PET Quantitation Of Insulin Action In Muscle
    Multi-Tracer PET Quantitation Of Insulin Action In MuscleNational Center For Research Resources
    2005 - 2005
  • Multi-Tracer PET Quant Skeletal Muscle Insulin Resist  Type 2 Diabetes Mellitus
    Multi-Tracer PET Quant Skeletal Muscle Insulin Resist Type 2 Diabetes MellitusNational Center For Research Resources
    2005 - 2005
  • Contrast Enhanced US Capillary Recruit Muscle
    Contrast Enhanced US Capillary Recruit MuscleNational Center For Research Resources
    2004 - 2004
  • Look Ahead: Fat Cell Size, Muscle Lipid Infiltration
    Look Ahead: Fat Cell Size, Muscle Lipid InfiltrationNational Center For Research Resources
    2004 - 2004
  • Mitochondrial Impairment In Muscle Insulin Resistance
    Mitochondrial Impairment In Muscle Insulin ResistanceNational Center For Research Resources
    2004 - 2005
  • Mitochondrial Impairment In Muscle Insulin Resistance
    Mitochondrial Impairment In Muscle Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases
    2004 - 2006
  • PET Quant Skeletal Muscle Insulin Resist NIDDM
    PET Quant Skeletal Muscle Insulin Resist NIDDMNational Center For Research Resources
    2004 - 2004
  • Look Ahead Study: Action For Health In Diabetes
    Look Ahead Study: Action For Health In DiabetesNational Center For Research Resources
    2004 - 2005
  • Multi-Tracer PET Quantitation Of Insulin In Muscle
    Multi-Tracer PET Quantitation Of Insulin In MuscleNational Center For Research Resources
    2004 - 2004
  • Look Ahead: MRI Derived Organ/Tissue Weight Loss
    Look Ahead: MRI Derived Organ/Tissue Weight LossNational Center For Research Resources
    2004 - 2004
  • Look Ahead Ancillary Study: MRI Derived Organ And Tissue Mass Changes With
    Look Ahead Ancillary Study: MRI Derived Organ And Tissue Mass Changes WithNational Center For Research Resources
    2004 - 2005
  • Study Of Health Outcomes Of Weight-Loss (SHOW)
    Study Of Health Outcomes Of Weight-Loss (SHOW)National Institute Of Diabetes And Digestive And Kidney Diseases
    2003 - 2005
  • Multi-Tracer PET Quantitation Of Insulin Action
    Multi-Tracer PET Quantitation Of Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases
    2002 - 2004
  • Glucagon Receptor Antagonist BAY 27 9955 In NIDDM
    Glucagon Receptor Antagonist BAY 27 9955 In NIDDMNational Center For Research Resources
    2000 - 2002
  • Skeletal Muscle Metabolism Of Fatty Acids
    Skeletal Muscle Metabolism Of Fatty AcidsNational Institute Of Diabetes And Digestive And Kidney Diseases
    2000 - 2004
  • Troglitazone, Metformin, &Sulfonylurea In Insulin Stimulated Glucose
    Troglitazone, Metformin, &Sulfonylurea In Insulin Stimulated GlucoseNational Center For Research Resources
    1999 - 2002
  • Effects Of Obesity On Muscle FFA Utilization
    Effects Of Obesity On Muscle FFA UtilizationNational Center For Research Resources
    1999 - 2002
  • Troglitazone, Metformin &Sulfonylurea And Insulin Stimulated Glucose
    Troglitazone, Metformin &Sulfonylurea And Insulin Stimulated GlucoseNational Center For Research Resources
    1999 - 1999
  • Effects Of Obesity On Muscle Free Fatty Acid Utilization
    Effects Of Obesity On Muscle Free Fatty Acid UtilizationNational Center For Research Resources
    1999 - 1999
  • SDZ Djn608 &Glyburideon In Basal &Postprandial Hepatic Glucose
    SDZ Djn608 &Glyburideon In Basal &Postprandial Hepatic GlucoseNational Center For Research Resources
    1999 - 2002
  • Obesity/Nutrition Research Center
    Obesity/Nutrition Research CenterNational Institute Of Diabetes And Digestive And Kidney Diseases
    1999 - 2006
  • Clinical Center For Look Ahead: Health In Diabetes
    Clinical Center For Look Ahead: Health In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases
    1999 - 2002
  • FFA Metabolism By Skeletal Muscle In Niddm--Regulation By Short Term  Calories
    FFA Metabolism By Skeletal Muscle In Niddm--Regulation By Short Term CaloriesNational Center For Research Resources
    1998 - 1999
  • Lipid Metabolism In Pregnancy And With Preeclampsia
    Lipid Metabolism In Pregnancy And With PreeclampsiaNational Center For Research Resources
    1998 - 2002
  • Obesity Effects On Muscle FFA Utilization
    Obesity Effects On Muscle FFA UtilizationNational Institute Of Diabetes And Digestive And Kidney Diseases
    1998 - 2001
  • Clinafloxacin Effects On Sulfonylurea Control Of Glucose In NIDDM
    Clinafloxacin Effects On Sulfonylurea Control Of Glucose In NIDDMNational Center For Research Resources
    1998 - 2000
  • Examination Of Skeletal Muscle Fat Content By Mri--Efects Of Obesity And NIDDM
    Examination Of Skeletal Muscle Fat Content By Mri--Efects Of Obesity And NIDDMNational Center For Research Resources
    1998 - 2002
  • Single Dose Study In Healthy Volunteers To Determine The Effect Of Clinafloxacin
    Single Dose Study In Healthy Volunteers To Determine The Effect Of ClinafloxacinNational Center For Research Resources
    1997 - 1999
  • Core--Clinical Assessment Facility
    Core--Clinical Assessment FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases
    1996 - 2002
  • Effects Of NIDDM On Glucose Transport In Skeletal Muscle
    Effects Of NIDDM On Glucose Transport In Skeletal MuscleNational Center For Research Resources
    1996 - 2002
  • Effects Of Visceral Obesity On Muscle FFA Metabolism
    Effects Of Visceral Obesity On Muscle FFA MetabolismNational Center For Research Resources
    1996 - 1999
  • In Vivo Assessment Of Skeletal Muscle Glucose Transport In NIDDM
    In Vivo Assessment Of Skeletal Muscle Glucose Transport In NIDDMNational Center For Research Resources
    1996 - 1996
  • Placebo-Controlled Safety And Efficacy Study Of Pimagedine In Type II Diabetes
    Placebo-Controlled Safety And Efficacy Study Of Pimagedine In Type II DiabetesNational Center For Research Resources
    1996 - 1996
  • Skeletal Muscle Free Fatty Acid Uptake And Oxidation In Obesity
    Skeletal Muscle Free Fatty Acid Uptake And Oxidation In ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases
    1996 - 1996
  • Skeletal Muscle FFA Oxidation During Exercise In NIDDM
    Skeletal Muscle FFA Oxidation During Exercise In NIDDMNational Center For Research Resources
    1996 - 1996
  • Six-Month Double-Blind Placebo-Controlled Study Of Troglitazone In NIDDM
    Six-Month Double-Blind Placebo-Controlled Study Of Troglitazone In NIDDMNational Center For Research Resources
    1996 - 1997
  • Visceral Obesity Effect On Muscle FFA Utilization
    Visceral Obesity Effect On Muscle FFA UtilizationNational Institute Of Diabetes And Digestive And Kidney Diseases
    1995 - 1997

Alternate Names

  • Dr. David Kelley, Dr. David Kelley, MD, Dr. D Kelley, Dr. David E Kelley

18 Colleague Invites!
Is this you? If so, register to see 18 messages.

Physicians, view Dr. Kelley's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV